Fingerprint
Dive into the research topics of 'The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: Results of a phase Ib dose-escalation, open-label study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically